Therapies

Our innovative therapies are advancing the treatment of diseases

Learn more about our portfolio of services and innovative therapies by visiting the product websites or by downloading patient or prescribing information.

Visit Websites
 
Prescribing InformationPatient InformationPatent Information
Abraxane® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)Prescribing InformationPatient InformationPatent Information
Istodax® (romidepsin)Prescribing InformationPatient InformationPatent Information
Otezla® (apremilast)Prescribing InformationPatent Information
Pomalyst® (pomalidomide)Prescribing InformationPatient InformationPatent Information
Revlimid® (lenalidomide)Prescribing InformationPatient InformationPatent Information
Thalomid® (thalidomide)Prescribing InformationPatient InformationPatent Information
VIDAZA® (azacitidine)Prescribing Information

ABRAXANE®, ISTODAX®, OTEZLA®, POMALYST®, REVLIMID®, THALOMID®, VIDAZA® are registered trademarks of Celgene Corporation.

These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed in Global Office Network under About).